Anadolu Medical Center
Immunotherapy in Istanbul typically costs from $3,000 to $3,000 per cycle. Final costs depend on the drug type, dosage, and number of treatment cycles required. Patients save around 89% compared to the US, where this procedure costs $30,000 on average. Standard prices generally cover the medication and infusion service, though diagnostic staging and molecular profiling are additional.
Bookimed Expert Insight: Istanbul is Turkey's primary oncology hub where clinics like Anadolu Medical Center maintain direct affiliation with Johns Hopkins Medicine. This partnership gives patients access to US-style treatment protocols at local rates. Experts like Professor Yesim Yildirim combine JCI-accredited safety with ESMO-certified precision. Many patients find value by choosing clinics that offer integrated molecular profiling. This ensures the immunotherapy drug is a perfect match before starting expensive cycles.
| Istanbul | Austria | Spain | |
| Immunotherapy | from $3,000 | ≈ $9,000 | from $4,000 |
| Sarcoma Immunotherapy | from $8,900 | ≈ $60,000 | from $6,200 |
| Immunotherapy for prostate cancer | from $8,000 | ≈ $30,000 | from $6,200 |
| Immunotherapy for lung cancer | from $8,000 | ≈ $30,000 | from $5,000 |
| Immunotherapy for kidney cancer | from $8,000 | ≈ $28,000 | from $2,200 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy journey.
Day 1
Day 2
Day 3
Day 4
Day 5 to Day 7
Week 2
Week 3
Week 4
Please note that each patient"s case is unique and the above schedule can change depending on the patient"s health condition and response to the treatment.
Dr. Bülent Karagöz specializes in tumor immunology and cancer immunotherapy with over 33 years of experience. He leads the Medical Oncology Department at Anadolu Medical Center.
Dr. Zafer Gulbas founded and directs Turkey’s largest Bone Marrow Transplant Center at Anadolu Medical Center. He is a hematologist-oncologist specializing in complex blood cancers and clotting disorders. Dr. Gulbas trained at top global institutions, including MD Anderson and Fred Hutchinson in the USA. He performs autologous and allogeneic transplants for leukemia, lymphoma, and aplastic anemia.
Prof. Sezer Sağlam specializes in immunotherapy at Gayrettepe Florence Nightingale Hospital, with extensive experience in gastrointestinal oncology.
Dr. Mehmet Salih Iyikesici is a medical oncologist. His work focuses on metabolically supported chemotherapy (MSCT), ketogenic diet–supported cancer care, hyperthermia, hyperbaric oxygen therapy, and insulin potentiation therapy. He emphasizes care for breast, pancreatic, and gastric cancers.
He is a Medical Oncology Specialist at Neolife Medical Center (2026–present). He previously served at Private Bahçelievler Medical Park (2013–2026), Medicana Beylikdüzü (2010–2013), Silivri Anadolu (2009–2010), Diyarbakır Training and Research (2008–2009), and Bursa Çekirge State (2006–2008). Earlier, he worked as an Internal Medicine Specialist (1997–2003). He was an Assistant Professor at Altınbaş University (2014–2026).
Training: Medical Oncology subspecialty, Marmara University (2003–2006). Internal Medicine, Istanbul Haydarpaşa Numune (1992–1996). Medicine, Uludağ University (1985–1990). Member, Medical Oncology Association (since 2004). His recent research (2019–2020) covers gastric, breast, pancreatic, and lung cancers. Topics include long‑term survival in metastatic pancreatic cancer and feasibility in metastatic non‑small cell lung cancer (NSCLC).
Written by Kateryna Zamkovska